Tags
- 3
- A
- A Black Box
- Administration
- Adoptive cell transfer
- Advanced
- Adverse
- Adverse effect
- Adverse event
- Adverse Events
- Agriculture in the United States
- Altered
- An
- Antigen
- Antigen receptor
- Approved
- Asse
- Assessment
- Axicabtagene ciloleucel
- Being
- Benefit
- Benefits
- Black
- Black Box
- Blood
- Boxed warning
- Breast
- Breast cancer
- Cancer
- Cancer Cell
- Cancer risk
- Car
- Care
- Carry
- Car-t therapy
- CBR
- Cell
- Cells
- Cell Therapy
- Chimera
- Chimeric antigen receptor
- Class
- Clinical
- Clinical trial
- Clinical trial participant
- Clinical Trials
- Come
- Concern
- Conduct
- Cost overrun
- CRS
- Cutaneous T cell lymphoma
- Cytokine
- Cytokine release
- Cytokine release syndrome
- Data
- Death
- Destroy
- Detail
- Determined
- Develop
- Diagnosis
- Disease
- Documented
- Dose
- Drug
- Drug class
- Drug discovery
- Drugs
- Effect
- Experienced
- Experimental
- Failure
- FDA
- Fda-approved
- Fifth grade
- Five
- Food
- Food and Drug Administration
- Four
- Frequently
- Gene therapy
- Genetic Engineering
- Genetics
- Grade
- Grade 3
- Granularity
- Health
- Health care
- Health outcome
- Health outcomes
- Health professional
- Hospital
- If
- Immune
- Immunotherapy
- Incidents
- Include
- Indication
- Inflammation
- Initial
- In-phase and quadrature components
- Investigation
- Investigational New Drug
- Known
- Kymriah
- Last month
- Leukemia
- Link
- Long term
- Lung cancer
- Lung inflammation
- Lyell
- Lymphocytosis
- Lymphoma
- Manufacturing
- Market
- Medication
- Metastases
- Metástasis
- Modified
- Most
- Multiple myeloma
- Neoplasm
- New
- No
- Noted
- Number
- Observation
- Observational study
- Only
- Over
- Panel
- Participation
- Patient
- Peripheral
- Peripheral T-cell lymphoma
- Pharmaceutical drug
- Phase
- Phase 1
- Phases of clinical research
- Pneumonitis
- Press release
- Product
- Professional
- Promise
- Promising
- Receptor
- Recommendation
- Refractory
- Relapse
- Reoccurring
- Requirement
- Research
- Researcher
- Respiratory failure
- Respiratory system
- Result
- Revealing
- Risk
- Scientific
- Second
- Secondary
- Selected
- Sensor
- Severity
- Side Effects
- Six
- Sixth
- Skin
- Some
- Still
- Suffering
- Suggest
- Syndrome
- T cell
- T-cell lymphoma
- The Drugs
- Therapy
- The Side Effects
- Tide
- Tisagenlecleucel
- To the Death
- Toxicity
- Treatment of cancer
- Trial
- Trials
- Triple-negative breast cancer
- Tumors of the hematopoietic and lymphoid tissues
- Unsure
- Uses
- Warn
- Warning
- Warnings
- White blood cell
- Who